Back

Suboptimal cardioprotective medication prescribing in patients with diabetes and stage B heart failure

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: pharmacotherapy (1) Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Muhammad Shahbaz Hussain

Dundee (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Efficacy of Semaglutide in glycemic control, weight loss, and improving lipid profile- the role of baseline vitamin D levels.
Professor R. Abo Fanne (Hadera, IL)
Abstract Slides
Presentation thumbnail
The association between SGLT2 inhibitors and new-onset osteoporosis in patients with type 2 diabetes: a population-based longitudinal cohort study
Doctor C. Chang (Taichung, TW)
Abstract Slides
Presentation thumbnail
Parallel disease trajectories of peripheral neurovascular disease and heart failure in type 2 diabetes mellitus: a 12-year prospective follow-up
Doctor D. Andric (Novi Sad, RS)
Abstract Slides
Presentation thumbnail
Effects of semaglutide and dapagliflozin on natriuretic peptides in type 2 diabetes: a randomized comparative study
Doctor C. Lejonberg (Helsingborg, SE)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart: pharmacotherapy (1)

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Diabetes and contemporary treatment of chronic heart failure in a large real-world heart failure population
29 June 2021
thumbnail
Congress Presentation
Symptoms still trump natriuretic peptide in predicting hospitalisation in matched Stage B and C populations
22 May 2023
thumbnail
Congress Presentation
NT-proBNP levels in diabetic cardiomyopathy: results from the ARISE-HF trial
20 May 2023
thumbnail
Congress Presentation
Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources